Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,73 USD | +3,41% | +0,74% | +72,78% |
Attività
Numero di dipendenti: 37
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Bispecific Antibodies
100,0
%
| 20 | 100,0 % | 7 | 100,0 % | -64,09% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Netherlands
100,0
%
| 20 | 100,0 % | 7 | 100,0 % | -64,09% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 56 | 01/06/19 | |
Fred M. Powell
DFI | Director of Finance/CFO | 63 | 01/11/22 |
Chief Tech/Sci/R&D Officer | - | 09/11/21 | |
Chief Tech/Sci/R&D Officer | 50 | 01/01/17 | |
Chief Tech/Sci/R&D Officer | 59 | 06/02/23 | |
Chief Tech/Sci/R&D Officer | 60 | 01/05/18 | |
Robin Hume
LAW | General Counsel | - | 15/05/23 |
Human Resources Officer | - | 09/11/21 | |
Amy Garabedian
LAW | General Counsel | - | 27/07/21 |
Peter Ros
PRN | Corporate Officer/Principal | 52 | 01/01/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 56 | 01/06/19 | |
Karen Wilson
BRD | Director/Board Member | 61 | 01/04/21 |
James Noble
BRD | Director/Board Member | 65 | 15/06/22 |
Peter Kiener
BRD | Director/Board Member | 72 | 01/01/23 |
Jay Backstrom
BRD | Director/Board Member | 69 | 15/06/22 |
Kapil Dhingra
CHM | Chairman | 64 | 22/02/21 |
Mary Wadlinger
BRD | Director/Board Member | 64 | 01/01/23 |
Christy Oliger
BRD | Director/Board Member | 54 | 09/03/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 26 289 087 | 18 738 315 ( 71,28 %) | 0 | 71,28 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+72,78% | 71,77 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione LVTX
- Società LAVA Therapeutics N.V.